Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-04-16 Sale | 2024-04-18 4:49 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume PRESIDENT & CSO | 50,000 | $14.2 | $710,195 | 808,638 (Direct) | View |
2024-04-04 Sale | 2024-04-05 5:37 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume PRESIDENT & CSO | 20,000 | $11.15 | $223,036 | 628,359 (Direct) | View |
2024-03-14 Purchase | 2024-03-18 4:06 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason CHIEF EXECUTIVE OFFICER | 4,400 | $11.31 | $49,771 | 171,620 (Direct) | View |
2024-01-04 Sale | 2024-01-05 4:03 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly SVP, Finance and CAO | 2,717 | $13.6 | $36,957 | 78,591 (Direct) | View |
2023-12-29 Sale | 2024-01-03 4:28 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly SVP, Finance and CAO | 1,631 | $15.04 | $24,530 | 81,308 (Direct) | View |
2023-12-29 Sale | 2024-01-03 4:25 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer | 3,128 | $15.04 | $47,045 | 312,349 (Direct) | View |
2023-12-29 Sale | 2024-01-03 4:20 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | GARCIA PETER S Chief Financial Officer | 1,893 | $15.04 | $28,471 | 85,348 (Direct) | View |
2023-12-29 Sale | 2024-01-03 4:17 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President & CSO | 7,179 | $15.04 | $107,972 | 618,359 (Direct) | View |
2023-07-06 Sale | 2023-07-07 4:09 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly VP, Finance and CAO | 7,345 | $6.52 | $47,889 | 55,713 (Direct) | View |
2023-06-30 Sale | 2023-07-05 5:09 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer | 1,605 | $7.34 | $11,781 | 281,477 (Direct) | View |
2023-06-30 Sale | 2023-07-05 5:07 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President & CEO | 3,208 | $7.34 | $23,547 | 536,538 (Direct) | View |
2023-06-30 Sale | 2023-07-05 5:05 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly VP, Finance and CAO | 466 | $7.34 | $3,420 | 63,058 (Direct) | View |
2023-06-30 Sale | 2023-07-05 5:00 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | GARCIA PETER S Chief Financial Officer | 887 | $7.34 | $6,511 | 54,738 (Direct) | View |
2022-12-29 Sale | 2023-01-03 8:52 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly VP, Finance and CAO | 482 | $11.07 | $5,336 | 62,097 (Direct) | View |
2022-12-29 Sale | 2023-01-03 8:47 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer | 1,617 | $11.07 | $17,901 | 270,253 (Direct) | View |
2022-12-29 Sale | 2023-01-03 8:34 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | GARCIA PETER S Chief Financial Officer | 893 | $11.07 | $9,886 | 53,723 (Direct) | View |
2022-12-29 Sale | 2023-01-03 8:29 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President & CEO | 3,232 | $11.07 | $35,779 | 539,746 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-04-16 Exercise | 2024-04-18 4:49 pm | N/A N/A | ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume PRESIDENT & CSO | 25,846 | $0.99 | 808,638 (Direct) | View |
2024-04-16 Exercise | 2024-04-18 4:49 pm | N/A 2027-03-30 | ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume PRESIDENT & CSO | 25,846 | $0 | 808,638 (Direct) | View |
2024-02-14 Option Award | 2024-02-16 6:24 pm | N/A 2034-02-13 | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly SVP, FINANCE AND CAO | 50,000 | $0 | 128,591 (Direct) | View |
2024-02-14 Option Award | 2024-02-16 6:21 pm | N/A 2034-02-13 | ALX ONCOLOGY HOLDINGS INC | ALXO | GARCIA PETER S CHIEF FINANCIAL OFFICER | 105,000 | $0 | 190,348 (Direct) | View |
2024-02-14 Option Award | 2024-02-16 6:17 pm | N/A 2034-02-13 | ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia CHIEF MEDICAL OFFICER | 125,000 | $0 | 437,349 (Direct) | View |
2024-02-14 Option Award | 2024-02-16 6:09 pm | N/A 2034-02-13 | ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume PRESIDENT & CSO | 125,000 | $0 | 743,359 (Direct) | View |
2024-02-14 Option Award | 2024-02-16 6:03 pm | N/A 2034-02-13 | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason CHIEF EXECUTIVE OFFICER | 250,000 | $0 | 357,220 (Direct) | View |
2023-09-08 Option Award | 2023-09-12 4:24 pm | N/A 2033-09-07 | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason Chief Executive Officer | 1,200,000 | $0 | 1,200,000 (Direct) | View |
2023-07-25 Option Award | 2023-07-27 4:27 pm | N/A 2033-07-24 | ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer | 141,000 | $0 | 422,477 (Direct) | View |
2023-07-25 Option Award | 2023-07-27 4:19 pm | N/A 2033-07-24 | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly SVP, Finance and CAO | 62,000 | $0 | 117,713 (Direct) | View |
2023-07-25 Option Award | 2023-07-27 4:15 pm | N/A 2033-07-24 | ALX ONCOLOGY HOLDINGS INC | ALXO | GARCIA PETER S Chief Financial Officer | 133,000 | $0 | 187,738 (Direct) | View |
2023-07-25 Option Award | 2023-07-27 4:11 pm | N/A 2033-07-24 | ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President & CEO | 371,000 | $0 | 907,538 (Direct) | View |
2023-06-20 Option Award | 2023-06-22 4:51 pm | N/A 2033-06-19 | ALX ONCOLOGY HOLDINGS INC | ALXO | Nielsen Jack Director 10% Owner | 20,200 | $0 | 20,200 (Direct) | View |
2023-06-20 Option Award | 2023-06-22 4:46 pm | N/A 2033-06-19 | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason Director 10% Owner | 20,200 | $0 | 20,200 (Direct) | View |
2023-06-20 Option Award | 2023-06-22 4:43 pm | N/A 2033-06-19 | ALX ONCOLOGY HOLDINGS INC | ALXO | Hemrajani Rekha Director | 20,200 | $0 | 20,200 (Direct) | View |
2023-06-20 Option Award | 2023-06-22 4:32 pm | N/A 2033-06-19 | ALX ONCOLOGY HOLDINGS INC | ALXO | GOODMAN COREY S Director 10% Owner | 20,200 | $0 | 20,200 (Direct) | View |
2023-06-20 Option Award | 2023-06-22 4:30 pm | N/A 2033-06-19 | ALX ONCOLOGY HOLDINGS INC | ALXO | Garland J. Scott Director | 10,100 | $0 | 10,100 (Direct) | View |
2023-06-20 Option Award | 2023-06-22 4:27 pm | N/A 2033-06-19 | ALX ONCOLOGY HOLDINGS INC | ALXO | Canamasas Itziar Director | 20,200 | $0 | 20,200 (Direct) | View |
2023-06-09 Exercise | 2023-06-13 4:38 pm | N/A N/A | ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer | 2,546 | $4.08 | 394,795 (Direct) | View |
2023-06-09 Exercise | 2023-06-13 4:38 pm | N/A N/A | ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer | 6,256 | $4.81 | 394,795 (Direct) | View |
2023-06-09 Exercise | 2023-06-13 4:38 pm | N/A N/A | ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer | 4,027 | $1.91 | 394,795 (Direct) | View |
2023-06-09 Exercise | 2023-06-13 4:38 pm | N/A 2029-09-12 | ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer | 12,829 | $0 | 394,795 (Direct) | View |
2022-12-16 Exercise | 2022-12-20 5:08 pm | N/A N/A | ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer | 12,731 | $4.08 | 396,412 (Direct) | View |
2022-12-16 Exercise | 2022-12-20 5:08 pm | N/A N/A | ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer | 25,339 | $4.81 | 396,412 (Direct) | View |
2022-12-16 Exercise | 2022-12-20 5:08 pm | N/A N/A | ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer | 8,404 | $1.91 | 396,412 (Direct) | View |
2022-12-16 Exercise | 2022-12-20 5:08 pm | N/A 2029-09-12 | ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer | 46,474 | $0 | 396,412 (Direct) | View |
2022-11-28 Option Award | 2022-11-29 4:32 pm | N/A 2032-11-28 | ALX ONCOLOGY HOLDINGS INC | ALXO | Garland J. Scott Director | 24,009 | $0 | 24,009 (Direct) | View |
2022-08-05 Option Award | 2022-08-09 6:10 pm | N/A 2032-08-04 | ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer | 160,000 | $0 | 348,396 (Direct) | View |
2022-08-05 Option Award | 2022-08-09 6:07 pm | N/A 2032-08-04 | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly VP, Finance and CAO | 47,000 | $0 | 98,718 (Direct) | View |
2022-08-05 Option Award | 2022-08-09 5:57 pm | N/A 2032-08-04 | ALX ONCOLOGY HOLDINGS INC | ALXO | GARCIA PETER S Chief Financial Officer | 124,000 | $0 | 150,178 (Direct) | View |